Clindamycin-associated hepatotoxicity.
D000293:Adolescent; D000469:Alkaline Phosphatase / Q000097:blood; D001219:Aspartate Aminotransferases / Q000097:blood; D001706:Biopsy; D001769:Blood / Q000382:microbiology; D002512:Cephalothin / Q000627:therapeutic use; D056486:Chemical and Drug Induced Liver Injury / Q000209:etiology* / Q000473:pathology; D002981:Clindamycin / Q000008:administration & dosage / Q000009:adverse effects* / Q000627:therapeutic use; D004697:Endocarditis, Bacterial / Q000188:drug therapy / Q000382:microbiology; D006801:Humans; D007275:Injections, Intravenous; D008099:Liver / Q000473:pathology; D008169:Lung Abscess / Q000188:drug therapy; D008297:Male; D013203:Staphylococcal Infections / Q000188:drug therapy / Q000382:microbiology; D013210:Staphylococcus / Q000302:isolation & purification; D014640:Vancomycin / Q000627:therapeutic use
D002981:Clindamycin; D014640:Vancomycin; D001219:Aspartate Aminotransferases; D000469:Alkaline Phosphatase; D002512:Cephalothin